Systematic drugs as a risk factor for periodontal disease initiation and progression.
There are many systemic drugs taken by patients that affect their periodontal statuses. Dentists are in a position to diagnose and manage these problems and, when appropriate, discuss possible alternative drug therapies with physician colleagues.
Rees
T D
TD
Department of Periodontics, Baylor College of Dentistry, Dallas, Texas, USA.
Levine
R A
RA
D002121:Calcium Channel Blockers / Q000009:adverse effects*; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D005351:Fibromatosis, Gingival / Q000139:chemically induced*; D005885:Gingival Hyperplasia / Q000139:chemically induced*; D012739:Gonadal Steroid Hormones / Q000009:adverse effects; D006801:Humans; D008297:Male; D009543:Nifedipine / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects*
D002121:Calcium Channel Blockers; D012739:Gonadal Steroid Hormones; D010672:Phenytoin; D016572:Cyclosporine; D009543:Nifedipine